产品详情
简单介绍：
Anti-ELL抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-ELL抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-ELL
Cat. Number:
Anti-ELL抗体KL-8515R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA. This is a multistep process,
Anti-ELL抗体called the transcription cycle, that includes five stages: preinitiation, promoter, clearance, elongation and termination. Elongation is thought to be a critical stage for the regulation of gene expression. ELL (11-19 lysine-rich leukemia protein), also designated MEN, functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II. It is also thought to regulate cellular proliferation. ELL is abundantly expressed in peripheral blood leukocytes, skeletal muscle, placenta and testis, with lower expression in spleen, thymus, heart, brain, lung, kidney, liver and ovary. The gene encoding human ELL, which maps to chromosome 19p13.1, is one of several genes that undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia. MLL (myeloid/lymphoid leukemia, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development.
Also known as:
ELL_HUMAN; Eleven nineteen
Anti-ELL抗体lysine rich leukemia gene; Eleven-nineteen lysine-rich leukemia protein; ELL1; elongation factor RNA polymerase II; Men; RNA polymerase II elongation factor; RNA polymerase II elongation factor ELL.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ELL.
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃
Anti-ELL抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-200 IF=1:50-200
Not yet tested in other applications. Anti-ELL抗体
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-ELL抗体
Optimal working dilutions must be determined by the end user.
kl014Bo01 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Ca01 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Cp01 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Ga01 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Po01 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Rb53 骨成型蛋白4(BMP4)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl015Hu01 骨成型蛋白受体1A(BMPR1A)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Mu01 骨成型蛋白受体1A(BMPR1A)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl015Ra01 骨成型蛋白受体1A(BMPR1A)多克隆抗体 Polyclonal Antibody to Bone Morphogenetic Protein Receptor 1A (BMPR1A)
kl017Bo01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ga01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Hu01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Mu01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Po01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl017Ra01 上皮性钙黏附蛋白(CDHE)多克隆抗体 Polyclonal Antibody to Cadherin, Epithelial (CDHE)
kl019Hu01 白介素8受体α(IL8Rα)多克隆抗体 Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
kl019Mu01 白介素8受体α(IL8Rα)多克隆抗体 Polyclonal Antibody to Interleukin 8 Receptor Alpha (IL8Ra)
